LOGIN 

 

JOIN

 

RENEW

2020 Virtual Mini Symposia Schedule

HomeMembersAssemblies and SectionsAbout2020 Virtual Mini Symposia Schedule ▶ CP - A92 and C15 - Predicting Outcomes and Medical and Interventional Management in COPD
CP - A92 and C15 - Predicting Outcomes and Medical and Interventional Management in COPD

 Date: Wednesday, November 4, 2020 

<Back to Mini Symposia Main Page

Maryl Kreider, Jennifer Taylor-Cousar and Jessica Bon 
Past, Present and Incoming CP Program Committee Chairs 

Moderated By: Meredith McCormack, MHS, MD, Collen Keyes, MD, MPH and Wassim Labaki, MD 

  • Impact of a Chronic Obstructive Pulmonary Disease Care Bundle on Hospital Readmission Rates - Katelyn Scannell, RN 

  • Respiratory Mortality and Hospitalizations Associated with Preserved Ratio Impaired Spirometry (PRISm): The NHLBI Pooled Cohorts Study - Emily Wan, MD, MPH 

  • A Predictive Model for COPD Exacerbations Using ProAir Digihaler: A 12-Week, OpenLabel Study – Laurie Snyder, MD 

  • Predictors of Mortality and Accelerated Loss of Lung Function in Smokers with FEV1/FVC ≥ 0.7: An Analysis of the COPDGene Cohort – Wassim Labaki, MD, MS 

  • CFTR Mutations Are Associated with Chronic Bronchitis in COPDGene Subjects - Aabida Saferali, PhD

  • Randomised Controlled Trial Assessing the Effect of Daily Doxycycline on Exacerbation Rate in Patients with COPD – Ben Vlies, MBChB, MRCP(UK)

  • Improvement in DLCO Following Bronchoscopic Lung Volume Reduction Therapy  – Massa Zantah, MD 

  • Augmentation Therapy for Alpha-1 Antitrypsin Deficiency: Improved Survival and Quality of Life Compared to Matched Augmentation Naive Controls Followed for Up to 15 Years – Robert Sandhaus, MD, PhD